Mason & Associates (California)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
3,414
+439
| +15% | +$81.5K | 0.15% | 67 |
|
|
2025
Q1 | $623K | Sell |
2,975
-1,531
| -34% | -$321K | 0.15% | 65 |
|
|
2024
Q4 | $801K | Buy |
4,506
+1,499
| +50% | +$266K | 0.19% | 58 |
|
|
2024
Q3 | $594K | Sell |
3,007
-354
| -11% | -$69.9K | 0.15% | 68 |
|
|
2024
Q2 | $576K | Sell |
3,361
-38
| -1% | -$6.52K | 0.15% | 61 |
|
|
2024
Q1 | $619K | Buy |
3,399
+1
| +0% | +$182 | 0.17% | 56 |
|
|
2023
Q4 | $527K | Buy |
3,398
+139
| +4% | +$21.5K | 0.15% | 53 |
|
|
2023
Q3 | $486K | Buy |
3,259
+1
| +0% | +$149 | 0.16% | 49 |
|
|
2023
Q2 | $439K | Buy |
3,258
+79
| +2% | +$10.6K | 0.13% | 55 |
|
|
2023
Q1 | $507K | Buy |
3,179
+2
| +0.1% | +$319 | 0.16% | 50 |
|
|
2022
Q4 | $513K | Sell |
3,177
-227
| -7% | -$36.7K | 0.16% | 47 |
|
|
2022
Q3 | $457K | Buy |
3,404
+2
| +0.1% | +$269 | 0.16% | 49 |
|
|
2022
Q2 | $521K | Sell |
3,402
-160
| -4% | -$24.5K | 0.18% | 50 |
|
|
2022
Q1 | $577K | Buy |
+3,562
| New | +$577K | 0.18% | 60 |
|